Compound information
- Natural Products
- ZC1218857
- Molecular Formula
- C22H26N2O6
- Molecular Weight
- 414.179086552 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-[[(2R)-2-(benzyloxycarbonylamino)-3-methyl-butanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid
- InChI
- InChI=1S/C22H26N2O6/c1-14(2)19(24-22(29)30-13-16-6-4-3-5-7-16)20(26)23-18(21(27)28)12-15-8-10-17(25)11-9-15/h3-11,14,18-19,25H,12-13H2,1-2H3,(H,23,26)(H,24,29)(H,27,28)/t18-,19+/m0/s1
- InChI Key
- YPLGNDYBRBVBCT-RBUKOAKNSA-N
- SMILES
- CC(C)[C@@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
- Source
- ZINC000004321884
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 124.96 Å2 | LogP | 2.577 |
LogS | -3.076 | LogD | 2.565 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.892 |
HIA | 0.895 | F20 % | 0.986 |
F30 % | 0.195 | Caco-2 | -6.243 |
MDCK | -5.609 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.037 | PPB | 61.111 |
VD | 0.215 | Fu | 0.651 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.003 | CYP1A2 substrate | 0.642 |
CYP2A6 substrate | 0.251 | CYP2B6 substrate | 0.374 |
CYP2C19 inhibitor | 0.113 | CYP2C19 substrate | 0.773 |
CYP2C8 substrate | 0.766 | CYP2C9 inhibitor | 0.028 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.05 |
CYP2D6 substrate | 0.397 | CYP2E1 substrate | 0.263 |
CYP3A4 inhibitor | 0.02 | CYP3A4 substrate | 0.864 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.965 | CL | 2.876 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.006 | Hepatotoxicity | 0.502 |
Mutagenicity | 0.161 | Rat Oral Acute Toxicity | 0.139 |
FDAMDD | 0.026 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.004 | Eye Corrosion | 0.004 |
Eye Irritation | 0.043 | Respiratory Toxicity | 0.0 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.553 | IGC50 | 2.455 |
LC50FM | 3.694 | LC50DM | 4.553 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.375 | NR-AR-LBD | 0.345 |
NR-AhR | 0.006 | NR-Aromatase | 0.044 |
NR-ER | 0.437 | NR-ER-LBD | 0.526 |
NR-PPAR-gamma | 0.595 | SR-ARE | 0.155 |
SR-ATAD5 | 0.361 | SR-HSE | 0.09 |
SR-MMP | 0.028 | SR-p53 | 0.073 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.